Final reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
12 May 2006. Related: Conference reports.
CROI 13 (Retrovirus) 2006
Regimen durability and toxicity in 36-month follow up on ART in Khayelitsha, South Africa
12 May 2006. Related: Conference reports, Side effects.
Adults in resource-limited settings are most likely to experience an HIV-associated Illness in the first three months from initiating therapy
12 May 2006. Related: Conference reports.
Causes of death in adults receiving ARV therapy in Senegal
12 May 2006. Related: Conference reports.
Rapid scale-up of treatment in Zambia delivered at primary health level
12 May 2006. Related: Conference reports.
The effect of HIV subtype on disease progression in Rakai, Uganda
12 May 2006. Related: Conference reports.
Genital tract pharmacokinetics of ten antiretroviral drugs in HIV-positive women
12 May 2006. Related: Conference reports, Women's health.
Initiation of ART leads to a rapid decline in cervical and vaginal HIV-1 RNA
12 May 2006. Related: Conference reports, Women's health.
Effect of HSV-2 treatment on HIV-1 genital shedding and plasma viral load
12 May 2006. Related: Conference reports, Women's health.
Once-daily FTC, ddI, and efavirenz in children and adolescents
12 May 2006. Related: Conference reports, Paediatric care.
Simplified triple NRTI regimen effective in vertically infected children: two years follow-up
12 May 2006. Related: Conference reports, Paediatric care.
Long-term clinical and biological outcomes in children vertically infected with HIV
12 May 2006. Related: Conference reports, Paediatric care.
Prospective follow up of children with lipodystrophy
12 May 2006. Related: Conference reports, Paediatric care.
Tuberculosis in HIV-positive children often missed from incidence data: the influence of HAART on paediatric TB
12 May 2006. Related: Conference reports, Paediatric care, TB coinfection.
Nevirapine pharmacokinetics with infant prophylaxis
12 May 2006. Related: Conference reports, Paediatric care.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
12 May 2006. Related: Conference reports, HIV prevention and transmission.
K65R frequently emerges within 1-6 weeks of tenofovir monotherapy in macaques
12 May 2006. Related: Conference reports, HIV prevention and transmission.
A genome armed against HIV
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Circumcision: a surprising benefit from an unkind cut
12 May 2006. Related: Conference reports, HIV prevention and transmission.
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, HIV prevention and transmission, Vaccines and microbicides.
Prevention of rectal transmission of SIV in macaques using FTC with tenofovir: FTC has independent protective effect even as monotherapy
3 May 2006. Related: Conference reports.
Further reports from 13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
13 April 2006. Related: Conference reports.
Pharmacokinetics of antiretrovirals in pregnancy: tenofovir, nelfinavir, lopinavir/r
13 April 2006. Related: Conference reports, Pregnancy.
Risk of central nervous system birth defects associated with ART exposure during pregnancy
13 April 2006. Related: Conference reports, Pregnancy.
No increase in adverse pregnancy outcomes in Thai women receiving nevirapine-containing HAART
13 April 2006. Related: Conference reports, Pregnancy.
ARV treatment following singe dose nevirapine exposure
13 April 2006. Related: Conference reports, Women's health.
Association of HIV replication capacity with mother to child transmission
13 April 2006. Related: Conference reports, Pregnancy.
Association between HIV subtype and detection of K103N
13 April 2006. Related: Conference reports, Pregnancy, Drug resistance.
Pharmacology and drug interaction studies in adults: summary table from CROI, ICAAC and EACS conferences
12 April 2006. Related: Conference reports, PK and drug interactions.
Other new antiretrovirals at Denver: the future seems bright
12 April 2006. Related: Conference reports, Antiretrovirals.
Origins of HIV traced to chimpanzees in Cameroon
12 April 2006. Related: Conference reports.
HSV-2 suppression reduces HIV and HSV shedding
12 April 2006. Related: Conference reports, HIV prevention and transmission.
13th Conference on Retroviruses and Opportunistic Infections (CROI), 5-8 February 2006, Denver
26 March 2006. Related: Conference reports.
Early integrase inhibitor studies in treatment experienced patients raise hopes for new drugs in a new class
25 March 2006. Related: Conference reports, Antiretrovirals.
Atazanavir in treatment naive patients, with and without ritonavir boosting
25 March 2006. Related: Conference reports, Antiretrovirals.
Simplification to atazanavir/ritonavir monotherapy
25 March 2006. Related: Conference reports, Treatment strategies.
Summary of STI studies: SMART shows clear increased risk from interrupting treatment at any CD4 count
25 March 2006. Related: Conference reports, Treatment strategies, Coinfections and complications.
The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy
25 March 2006. Related: Conference reports, Pregnancy.
Should criteria for initiation of HAART be revisited in pregnant women?
25 March 2006. Related: Conference reports, Pregnancy.
Cotrimoxazole prophylaxis in pregnancy
25 March 2006. Related: Conference reports, Pregnancy.
Treatment in primary HIV infection
25 March 2006. Related: Conference reports, Treatment strategies.
CNS penetration of ARV drugs is associated with lower CSF viral load
25 March 2006. Related: Conference reports, Antiretrovirals.
Sexual transmission of hepatitis C in HIV-positive men in the UK
25 March 2006. Related: Conference reports, Hepatitis coinfection.